BFONX
Biondo Focus Fund
1W: -0.9%
1M: -1.2%
3M: +3.7%
YTD: -0.6%
1Y: +6.1%
3Y: +75.9%
5Y: +24.3%
$21.19
+0.05 (+0.24%)
Weekly Expected Move ±1.8%
$20
$21
$21
$22
$22
Portfolio Health Summary
IS Overall Score
73.4
★★★★★
Altman Z-Score
18.31
Safe
Weight Coverage
78%
of portfolio analyzed
Holdings Matched
13
with fundamental data
InsiderStreet Scorecard
★★★★★
73.4
Top Holdings: Score Breakdown
Risk & Quality Signals
Altman Z-Score
18.31
Safe Zone (>2.99)
Piotroski F-Score
6.4 / 9
Moderate
Beneish M-Score
-2.33
Unlikely Manipulator
Credit Score
—
Earnings Quality
62.9 / 100
Portfolio Valuation
P/E
18.73x
P/B
6.14x
P/S
5.53x
EV/EBITDA
19.42x
EV/Revenue
6.64x
P/FCF
62.03x
P/OCF
18.46x
PEG
0.55x
Earnings Yield
5.34%
FCF Yield
1.61%
OCF Yield
5.42%
Median P/E
17.95x
Growth & Shareholder Returns
Year-over-Year Growth
Revenue
+14.8%
Net Income
+27.8%
EPS
+40.0%
FCF
+34.7%
EBITDA
+8.6%
Op. Income
—
Compound Growth Rates
Rev CAGR 3Y
+22.6%
Rev CAGR 5Y
+16.6%
EPS CAGR 3Y
+33.9%
EPS CAGR 5Y
+17.5%
FCF CAGR 3Y
+37.2%
FCF CAGR 5Y
+10.3%
EBITDA CAGR 3Y
+23.9%
EBITDA CAGR 5Y
+14.4%
Payout Ratio
15.56%
Buyback Yield
3.02%
Dividend Yield
0.77%
Total Shareholder Return
3.48%
Earnings Stability
Monte Carlo Price Simulation
Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.
Current Price
$21.14
Median 1Y
$22.70
5th Pctile
$14.75
95th Pctile
$34.94
Ann. Volatility
26.3%
25th–75th percentile
5th–95th percentile
Median path
Historical
All Ratios & Metrics
Valuation (12)
| Metric | Value |
|---|---|
| Portfolio P/E | 18.73 |
| Portfolio P/B | 6.14 |
| Portfolio P/S | 5.53 |
| EV/EBITDA | 19.42 |
| EV/Revenue | 6.64 |
| P/FCF | 62.03 |
| P/OCF | 18.46 |
| PEG | 0.55 |
| Earnings Yield | 5.34% |
| FCF Yield | 1.61% |
| OCF Yield | 5.42% |
| Median P/E | 17.95 |
Profitability & Returns (9)
| Metric | Value |
|---|---|
| Gross Margin | 59.61% |
| Operating Margin | 23.14% |
| Net Margin | 29.45% |
| FCF Margin | 8.73% |
| ROE | 39.55% |
| ROA | 21.75% |
| ROIC | 20.57% |
| ROCE | — |
| Asset Turnover | — |
Leverage & Solvency (6)
| Metric | Value |
|---|---|
| Debt/Equity | 0.37 |
| Debt/Assets | 0.21 |
| Net Debt/EBITDA | 0.02 |
| Interest Coverage | 41.76 |
| Current Ratio | 1.59 |
| Quick Ratio | 1.47 |
Efficiency (4)
| Metric | Value |
|---|---|
| Asset Turnover | — |
| Inventory Turnover | — |
| Receivables Turnover | — |
| Payables Turnover | — |
Growth — YoY (6)
| Metric | Value |
|---|---|
| Revenue Growth | 14.85% |
| Net Income Growth | 27.82% |
| EPS Growth | 39.97% |
| FCF Growth | 34.68% |
| EBITDA Growth | 8.62% |
| Op. Income Growth | — |
Growth — CAGR (16)
| Metric | Value |
|---|---|
| Revenue CAGR 3Y | 22.57% |
| Revenue CAGR 5Y | 16.55% |
| Revenue CAGR 10Y | — |
| EPS CAGR 3Y | 33.86% |
| EPS CAGR 5Y | 17.54% |
| EPS CAGR 10Y | — |
| FCF CAGR 3Y | 37.22% |
| FCF CAGR 5Y | 10.35% |
| FCF CAGR 10Y | — |
| EBITDA CAGR 3Y | 23.93% |
| EBITDA CAGR 5Y | 14.36% |
| EBITDA CAGR 10Y | — |
| Net Income CAGR 3Y | 32.85% |
| Net Income CAGR 5Y | 16.17% |
| Op. Income CAGR 3Y | — |
| Op. Income CAGR 5Y | — |
Quality Scores (13)
| Metric | Value |
|---|---|
| IS Overall | 73.4 |
| IS Profitability | 75.5 |
| IS Balance Sheet | 65.5 |
| IS Earnings Quality | 62.9 |
| IS Growth | 71.0 |
| IS Value | 34.6 |
| IS Momentum | 81.8 |
| IS Safety | 94.9 |
| IS Quality | 72.1 |
| Altman Z-Score | 18.31 |
| Piotroski F-Score | 6.43 |
| Beneish M-Score | -2.33 |
| Credit Score | — |
Dividends & Payout (4)
| Metric | Value |
|---|---|
| Dividend Yield | 0.77% |
| Payout Ratio | 15.56% |
| Buyback Yield | 3.02% |
| Total Shareholder Return | 3.48% |
Growth Stability (4)
| Metric | Value |
|---|---|
| Revenue Stability | 0.953 |
| Earnings Stability | 0.826 |
| Earnings Persistence | 0.791 |
| Margin Stability | 0.942 |
Medians (3)
| Metric | Value |
|---|---|
| Median P/E | 17.95 |
| Median P/B | 6.61 |
| Median Dividend Yield | — |
Coverage Meta (3)
| Metric | Value |
|---|---|
| Weight Coverage % | 77.85% |
| Holdings Matched | 13 |
| Total Holdings | 15 |